SmartTRAK takes a look at the trends impacting the Extremities Market in 2024 and beyond.
Among the many topics covered in detail in this market outlook article are:
- CMS Reimbursement Changes Accelerate Shift to Arthroplasty Site-of-Care
The Centers for Medicare and Medicaid Services’ (CMS) move to reimburse shoulder replacement and ankle replacement in an ambulatory surgery center (ASC) setting will accelerate the move of procedures to ... (read more) - An Increase in Pricing Pressure from the Shift to Shoulder ASC Procedures
The national average CMS facility reimbursement in 2024 for total shoulder arthroplasty in an ASC is approximately $14K, significantly lower than for hospital-based procedures in the range of ... (read more) - The Race is on for Shoulder Robotics
Stryker and Zimmer Biomet appear to be racing to the finish line to be the first to market in the US with a shoulder robotics solution. During Zimmer Biomet’s Q323 earnings call, CEO Ivan Tornos stated they plan to be first on ... (read more) - Focus on Hallux Valgus Procedures Continues to Propel Foot & Ankle Fixation Segment
The fast-paced world of extremities fixation shows no signs of slowing down anytime soon. Manufacturers continue to introduce new products with an increased focus on ... (read more)
SmartTRAK estimates the US Extremities Market will continue to grow in the ~7% range YoY driven by key introductions from historically large players, such as Stryker, DePuy Synthes, Smith & Nephew and Zimmer Biomet, as well as from other players solely focused on the Extremities segment. These are the players that will continue to take share. This includes companies like ...
To download and read the complete "Extremities Outlook 2024" Market Outlook article by Natasha Weeks, Managing Editor/Sr. Analyst Trauma & Extremities and Lisa Mahan, VP Product Development & IT, Sr. Analyst TJ&E, just click the button below. 
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK offers and how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.
